Wed, November 2, 2022
Tue, November 1, 2022
Mon, October 31, 2022
Sun, October 30, 2022
Fri, October 28, 2022

Whit Mayo Maintained (AMED) at Hold with Decreased Target to $96 on, Nov 1st, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-96-on-nov-1st-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Whit Mayo of SVB Leerink, Maintained "Amedisys, Inc." (AMED) at Hold with Decreased Target from $116 to $96 on, Nov 1st, 2022.

Whit has made no other calls on AMED in the last 4 months.



There are 8 other peers that have a rating on AMED. Out of the 8 peers that are also analyzing AMED, 1 agrees with Whit's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • John Ransom of "Raymond James" Downgraded from Buy to Hold on, Thursday, October 27th, 2022


These are the ratings of the 7 analyists that currently disagree with Whit


  • Frank Morgan of "RBC Capital" Maintained at Buy with Decreased Target to $139 on, Monday, October 31st, 2022
  • Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $145 on, Friday, October 28th, 2022
  • Sarah James of "Barclays" Maintained at Buy with Decreased Target to $126 on, Friday, October 28th, 2022
  • David Macdonald of "Truist Securities" Maintained at Strong Buy with Decreased Target to $130 on, Friday, October 28th, 2022
  • Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $165 on, Monday, October 24th, 2022
  • Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $135 on, Monday, October 3rd, 2022
  • Andrew Mok of "UBS" Downgraded from Hold to Strong Sell and Decreased Target to $95 on, Tuesday, August 2nd, 2022

Publication Contributing Sources